Welcome to our dedicated page for Forian news (Ticker: FORA), a resource for investors and traders seeking the latest updates and insights on Forian stock.
Forian Inc. reports developments tied to its data science-driven information and analytics business for life science, healthcare and financial services customers. Its updates center on proprietary data management capabilities, large-scale healthcare data assets, and analytics products used to measure operational, clinical and financial performance across life sciences, payer and provider markets.
Recurring news themes include quarterly financial results, data-platform investment, customer and marketplace access, and product activity around information assets such as Chartis and the Chronos data lake. Forian's completed acquisition of Kyber Data Science added machine learning-enabled healthcare analytics for financial services customers, while partnerships such as Databricks Marketplace distribution expand access to its healthcare information products.
Forian Inc. will join the Russell 3000 Index effective June 28, 2021, following the annual reconstitution. This inclusion, which captures the 4,000 largest US stocks by market capitalization, means Forian is also part of the large-cap Russell 1000 or small-cap Russell 2000 Index. CEO Dan Barton highlighted this milestone emphasizes the company's innovation in healthcare and cannabis technology. Russell indexes influence $10.6 trillion in assets, making membership significant for investment management and institutional strategies.
Forian Inc. (NASDAQ: FORA) reported significant growth in its fiscal Q1 2021, achieving $1.6 million in revenue, a staggering 2331% increase from $66,667 in Q1 2020. The company incurred a net loss of $4.5 million, a 565% rise compared to the prior year. Adjusted EBITDA was negative $2.9 million versus negative $0.7 million in 2020. The quarter included 29 days of Helix Technologies operations following a strategic business combination, reinforcing Forian's position in the healthcare and cannabis sectors. Additionally, the company raised $12 million through PIPE financing.
Forian Inc. (Nasdaq:FORA) will announce its financial results for Q1 2021 on May 17, 2021, before market opening. The announcement will be followed by a conference call at 8:30 a.m. ET the same day. This session aims to discuss the company's financial performance in detail. Interested participants can register for the conference call starting May 11, 2021, and access the earnings release at forian.com/investors.
Forian Inc. (Nasdaq:FORA) announced a successful securities purchase agreement, raising $12 million through a private investment in public equity (PIPE) financing. The deal involves the sale of 1,191,743 shares at an average price of $10.21 per share. Directors, including Executive Chairman Max Wygod, purchased 560,461 shares at $11.33 each, while unaffiliated investors acquired 631,282 shares at $8.95, a 15% discount to the previous day's trading price. Proceeds will support data acquisition and general corporate purposes.